Florian Wolfgang Kiefer

Florian Wolfgang Kiefer

Auto-generated profile, based on publicly available information

Florian Wolfgang Kiefer

Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
JHJoakim Huber
Joakim Huber
FKFlorian W. Kiefer
Florian W. Kiefer
MZMaximilian Zeyda
Maximilian Zeyda
BLBernhard Ludvik
Bernhard Ludvik
GSGerd R. Silberhumer
Gerd R. Silberhumer
TSThomas Michael Stulnig
Thomas Michael Stulnig
Background/Aims: Obesity is associated with a low-grade inflammation, insulin resistance, and macrophage infiltration of adipose tissue. The role of CC chemokines and their respective receptors in human adipose tissue inflammation remains to be determined. Methods: sc and visceral adipose tissue of obese patients (body mass index 53.1 ± 11.3 kg/m2) compared with lean controls (body mass index 25.9 ± 3.8 kg/m2) was analyzed for alterations in inflammatory gene expression. Results: Macrophage infiltration was increased in sc and visceral adipose tissue of obese patients as determined by increased mRNA expression of a macrophage-specific marker (CD68) and by elevated macrophage infiltration. Gene expression of CC chemokines involved in monocyte chemotaxis (CCL2, CCL3, CCL5, CCL7, CCL8, and CCL11) and their receptors (CCR1, CCR2, CCR3, and CCR5) was higher in sc and visceral adipose tissue of obese patients. Serum concentrations of the inflammatory marker IL-6 and C-reactive protein were elevated in obese patients compared with lean controls. Obese patients revealed increased insulin resistance as assessed by the homeostasis model assessment of insulin resistance index and reduced plasma adiponectin concentrations. Adipose tissue expression of many CC chemokines and their receptors in the obese group positively correlated with CD68 expression. Conclusion: Up-regulation of the CC chemokines and their respective receptors in adipose tissue occurs in human obesity and is associated with increased systemic inflammation.

6 May 2012 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
FKFlorian W Kiefer
Florian W Kiefer
CVCecile Vernochet
Cecile Vernochet
POPatrick O'Brien
Patrick O'Brien
SSSteffen Spoerl
Steffen Spoerl
JBJonathan D Brown
Jonathan D Brown
JPJorge Plutzky
Jorge Plutzky

1 July 2014 in Hormone Molecular Biology and Clinical Investigation
Verified
Journal Article
Closed access
AFAnna Fenzl
Anna Fenzl
FKFlorian W. Kiefer
Florian W. Kiefer
The growing understanding of adipose tissue as an important endocrine organ with multiple metabolic functions has directed the attention to the (patho)physiology of distinct fat depots. Brown adipose tissue (BAT), in contrast to bona fide white fat, can dissipate significant amounts of chemical energy through uncoupled respiration and heat production (thermogenesis). This process is mediated by the major thermogenic factor uncoupling protein-1 and can be activated by certain stimuli, such as cold exposure, adrenergic compounds or genetic alterations. White adipose tissue (WAT) depots, however, also possess the capacity to acquire brown fat characteristics in response to thermogenic stimuli. The induction of a BAT-like cellular and molecular program in WAT has recently been termed “browning” or “beiging”. Promotion of BAT activity or the browning of WAT is associated with in vivo cold tolerance, increased energy expenditure, and protection against obesity and type 2 diabetes. These preclinical observations have gained additional significance with the recent discovery that active BAT is present in adult humans and can be detected by 18 fluor-deoxy-glucose positron emission tomography coupled with computed tomography. As in rodents, human BAT can be activated by cold exposure and is associated with increased energy turnover and lower body fat mass. Despite the tremendous progress in brown fat research in recent years, pharmacological concepts to harness BAT function therapeutically are currently still lacking.

27 January 2010 in Diabetes
Verified
Journal Article
Open access
FKFlorian W. Kiefer
Florian W. Kiefer
MZMaximilian Zeyda
Maximilian Zeyda
KGKarina Gollinger
Karina Gollinger
BPBirgit Pfau
Birgit Pfau
ANAngelika Neuhofer
Angelika Neuhofer
TSThomas Michael Stulnig
Thomas Michael Stulnig
OBJECTIVE: Obesity is associated with a state of chronic low-grade inflammation mediated by immune cells that are primarily located to adipose tissue and liver. The chronic inflammatory response appears to underlie obesity-induced metabolic deterioration including insulin resistance and type 2 diabetes. Osteopontin (OPN) is an inflammatory cytokine, the expression of which is strongly upregulated in adipose tissue and liver upon obesity. Here, we studied OPN effects in obesity-induced inflammation and insulin resistance by targeting OPN action in vivo. RESEARCH DESIGN AND METHODS: C57BL/6J mice were fed a high-fat diet to induce obesity and were then intravenously treated with an OPN-neutralizing or control antibody. Insulin sensitivity and inflammatory alterations in adipose tissue and liver were assessed. RESULTS: Interference with OPN action by a neutralizing antibody for 5 days significantly improved insulin sensitivity in diet-induced obese mice. Anti-OPN treatment attenuated liver and adipose tissue macrophage infiltration and inflammatory gene expression by increasing macrophage apoptosis and significantly reducing c-Jun NH2-terminal kinase activation. Moreover, we report OPN as a novel negative regulator for the activation of hepatic signal transducer and activator of transcription 3 (STAT3), which is essential for glucose homeostasis and insulin sensitivity. Consequently, OPN neutralization decreased expression of hepatic gluconeogenic markers, which are targets of STAT3-mediated downregulation. CONCLUSIONS: These findings demonstrate that antibody-mediated neutralization of OPN action significantly reduces insulin resistance in obesity. OPN neutralization partially decreases obesity-associated inflammation in adipose tissue and liver and reverses signal transduction related to insulin resistance and glucose homeostasis. Hence, targeting OPN could provide a novel approach for the treatment of obesity-related metabolic disorders.

13 March 2014 in Diabetologia
Verified
Journal Article
Closed access
PDF file
AFAnna Fenzl
Anna Fenzl
BIBianca K. Itariu
Bianca K. Itariu
LKLana Kosi
Lana Kosi
MFMonika Fritzer-Szekeres
Monika Fritzer-Szekeres
Alexandra Kautzky-WillerAlexandra Kautzky-Willer
Alexandra Kautzky-Willer
FKFlorian W. Kiefer
Florian W. Kiefer

1 February 2011 in Metabolism
Verified
Journal Article
Closed access
JPJanina M Patsch
Janina M Patsch
FKFlorian W. Kiefer
Florian W. Kiefer
PVPeter Varga
Peter Varga
PPPamela Pail
Pamela Pail
MRMartina Rauner
Martina Rauner
PPPeter Pietschmann
Peter Pietschmann